Dr. Benet is a Professor of Biopharmaceutical Sciences and Pharmaceutical Chemistry at the University of California, San Francisco (UCSF), and is an internationally recognized authority on drug development. 

He is former Chair of the Departments of Pharmacy and Biopharmaceutical Sciences at UCSF (1978-1995), and currently lectures at UCSF on drug development and the operation of the FDA. 

Dr. Benet has founded three start-up pharmaceutical companies and holds eleven US patents on pharmaceutical compounds He has received six honorary doctorates. His research interests include pharmacokinetics, biopharmaceutics, drug delivery and pharmacodynamics, which has produced more than 490 publications and seven books. 

Dr. Benet is listed by ISI as one of the most highly cited pharmacologists worldwide. He presently serves on the Editorial boards of several biopharmaceutical journals. He is a Fellow of the Academy of Pharmaceutical Sciences and Research, the American Association of Pharmaceutical Scientists (AAPS) and of the American Association for the Advancement of Science (AAAS). He is past chair of the International Pharmaceutical Federation, and is a member of the Institute of Medicine of the National Academy of Sciences. 

He served as a member of the FDA Generic Drugs Advisory Committee and the FDA Science Board, and was the Chair of the CBER subcommittee of the FDA Science Board that delivered its review of science at the FDA in December 2007. He presently serves on the IOM Forum on Drug Discovery, Development and Translation, the Biodefense Standing Committee of the National Research Council and on the Boards of Directors of the American Foundation for Pharmaceutical Education, Impax Laboratories, and Institute for OneWorld Health. He is a Scientific Advisory Board Member and/or Consultant for more than 30 pharmaceutical and biotechnology companies.